Thermo Fisher Scientific has agreed to provide Premaitha Health a secured loan facility worth $5 million, of which $4 million will be immediately used as working capital for Premaitha's commercial growth strategies. Premaitha, which makes the Iona and Sage prenatal screening tests that operate on the DNA sequencing tools of Thermo Fisher, will draw down the remaining amount against performance milestones that will be reviewed quarterly.
Premaitha Health secures $5M loan facility from Thermo Fisher
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.